Winning comes naturally to GXPi
Posted: 11 September 2013 | | No comments yet
Regulatory compliance specialist GXPi has announced the appointment of Richard Winning…
Regulatory compliance specialist GXPi has announced the appointment of Richard Winning to help manage Product delivery and Migration and Quality Compliance services particularly emphasis in Clinical areas. Bringing 35 years of experience and an extensive knowledge of the pharmaceutical and biopharma industry, the appointment of Winning will be significant to GXPi’s ever growing presence within both these industries. As well as this, Winning has experience in delivering clinical trials programs, clinical IT systems and procedural management systems.
Chief Executive of GXPi, Keith William’s comments: “Richard’s appointment has come at an exciting time for the company. Having recently unveiled X-forms™, our latest extension to our X-docs™ advanced electronic document management platform, we are confident that Richard and his extensive experience in the pharmaceutical and biopharma industries and knowledge in consultancy and process improvement will prove to be a valuable addition to our team.”
GXPi provides expert consultancy to the global life sciences sector, delivering products and services designed specifically to meet complex compliance requirements. Simplifying sophisticated processes and technology environments to deliver compliance simply, ensures that customers can benefit from long-term solutions that can evolve with their needs.
Winning will be responsible for providing consultancy for customers that need a company with an extensive knowledge of the Pharma industry, particularly those who would benefit from having the capability to manage improved processes such as Trails Master Files (TMF), Regulatory Document Management and Procedural (SOP) Management. His first assignment will focus on document migration and the development of expertise in that area to support the implementation of X-docs™ installations.
Commenting on his appointment, Winning said: “I hope to build on GXPi’s excellent reputation for delivering effective solutions for customers in the life science sector. My new position offers me an excellent opportunity to use my knowledge and experience of pharmaceutical and biopharma industries, and to ensure that GXPi continues to provide its customers with excellent, cost effective, timely solutions.”